GIP/GLP-1/glucagon agonist
Retatrutide companies
Answer
Public registers name 8 bulk ingredient labelers, 3 trial sponsors, 21 companies with an FDA warning letter and 1 recalling firm for Retatrutide.
Each row is what a register states. A company named here is not endorsed or accused by this site.
BULK INGREDIENT LABELER
8 companies
Lists the bulk active ingredient with FDA (NDC directory).
| ETERNAL WEALTH(CHINA)LIMITED | Retatrutide, BULK INGREDIENT Regulator openFDA |
|---|---|
| Harbin Jixianglong Biotech Co., Ltd. | Retatrutide, BULK INGREDIENT Regulator openFDA |
| Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | Retatrutide, BULK INGREDIENT Regulator openFDA |
| Nanjing Hanxin Pharmaceutical Technology Co., Ltd. | Retatrutide, BULK INGREDIENT Regulator openFDA |
| Qingdao Biopeptek Co., Ltd. | Retatrutide, BULK INGREDIENT Regulator openFDA |
| Shanghai SynTheAll Pharmaceutical Co., Ltd. | Retatrutide, BULK INGREDIENT Regulator openFDA |
| Shenzhen Alvantis Pharma Co., Ltd. | RETATRUTIDE, BULK INGREDIENT Regulator openFDA |
| Sinopep-Allsino Biopharmaceutical Co., Ltd. | Retatrutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
TRIAL SPONSOR
3 companies
Sponsors registered clinical trials of the peptide.
| Eli Lilly & Company | 19 registered trials Trial register ClinicalTrials.gov |
|---|---|
| Eli Lilly & Co. | 8 registered trials Trial register EU CTIS |
| Hudson Biotech | 1 registered trial Trial register ClinicalTrials.gov |
WARNING LETTER RECIPIENT
21 companies
Received an FDA warning letter naming the peptide.
| Amazing Meds | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
|---|---|
| ASN-LABS | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Darmerica, LLC | CGMP/Active Pharmaceutical Ingredient (API)/Adulterated/Misbranded, 2025-12-08 Regulator FDA warning letters |
| EA WORKS Limited Liability Company dba Trust Labs | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| GenLabMeds | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| GenoGenix LLC | Compounding Pharmacy/Adulterated Drug Products, 2026-01-20 Regulator FDA warning letters |
| GLP-1 Solution | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Gram Peptides | Unapproved New Drugs Sold Over the Internet, 2026-03-31 Regulator FDA warning letters |
| Lovega LLC dba Pink Pony Peptides | Unapproved New Drugs Sold Over the Internet, 2026-03-31 Regulator FDA warning letters |
| MedClub by Dr. Jenn | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Mile High Compounds LLC | Unapproved New Drugs Sold Over the Internet, 2026-03-31 Regulator FDA warning letters |
| NuScience Peptides LLC | Unapproved New Drugs/Misbranded, 2026-08-24 Regulator FDA warning letters |
| Peak Performance Peptides | Unapproved New Drugs/Misbranded, 2026-08-24 Regulator FDA warning letters |
| Peptide Partners LLC | Unapproved New Drugs/Misbranded, 2026-08-24 Regulator FDA warning letters |
| Prime Sciences | Unapproved New Drugs Sold Over the Internet, 2026-03-31 Regulator FDA warning letters |
| Prime Vitality, Inc. dba Prime Peptides | Unapproved New Drugs/Misbranded, 2024-12-10 Regulator FDA warning letters |
| Royal Peptides LLC | Unapproved New Drugs/Misbranded, 2026-08-24 Regulator FDA warning letters |
| Summit Research Peptides | Unapproved New Drugs/Misbranded, 2024-12-10 Regulator FDA warning letters |
| Swisschems | Unapproved New Drugs/Misbranded, 2024-12-10 Regulator FDA warning letters |
| TXP Innovations LLC dba Tex Peptides | Unapproved New Drugs/Misbranded, 2026-08-24 Regulator FDA warning letters |
| Xcel Research LLC | Unapproved New Drugs/Misbranded, 2024-12-10 Regulator FDA warning letters |
RECALLING FIRM
1 company
Recalled a product naming the peptide (FDA enforcement report).
| GenoGenix LLC | Class II recall, Ongoing, 2025-10-15 Regulator openFDA |
|---|
Every company across all peptides: companies. Names are matched only when identical apart from case and punctuation, so one group can appear under two spellings.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.